Fairfield Financial Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,512
Closed -$246K – 216
2024
Q4
$246K Hold
1,512
– – 0.09% 59
2024
Q3
$295K Buy
1,512
+1
+0.1% +$184 0.1% 62
2024
Q2
$262K Buy
+1,511
New +$251K 0.08% 59
2023
Q4
$330K Buy
1,670
+237
+17% +$42K 0.13% 60
2023
Q3
$249K Buy
1,433
+1
+0.1% +$182 0.1% 56
2023
Q2
$247K Sell
1,432
-75
-5% -$13K 0.1% 61
2023
Q1
$247K Hold
1,507
– – 0.11% 63
2022
Q4
$221K Sell
1,507
-409
-21% -$60.5K 0.1% 61
2022
Q3
$284K Buy
1,916
+69
+4% +$11.5K 0.13% 53
2022
Q2
$317K Sell
1,847
-350
-16% -$60.5K 0.15% 50
2022
Q1
$414K Buy
+2,197
New +$434K 0.15% 52

Other funds holding ZTS

Fairfield Financial Advisors's ZTS Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of Zoetis (ZTS) in Q1 2025, closing a stake of 1,512 shares — an estimated $246K sold.

Fairfield Financial Advisors first reported a position in ZTS in Q1 2022 and held it in 11 quarters. The position peaked at $414K in Q1 2022. 1,891 funds tracked by Wall St. Rank hold ZTS as of Q1 2025.

  • Fairfield Financial Advisors reported no remaining Zoetis position as of Q1 2025 after selling out during the quarter.
  • Fairfield Financial Advisors sold 1,512 Zoetis shares in Q1 2025, an estimated $246K.
  • Fairfield Financial Advisors first reported a position in Zoetis in Q1 2022 and held it in 11 quarters.
  • Fairfield Financial Advisors's Zoetis position peaked at $414K in Q1 2022.
  • 1,891 funds tracked by Wall St. Rank held Zoetis as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.